Explore the vast range of titles available.

Room temperature phosphorescence (RTP) in metal‐free organic materials has attracted considerable attention due to its rich excited state properties, high quantum efficiency, long luminescence lifetimes, etc., showing great potential in organic optoelectronic devices, bioimaging, information anti‐counterfeiting, and so forth. The crystals have excellent rigidity and clear molecular packing patterns, which can effectively avoid non‐radiative transitions of excitons for phosphorescence enhancement. In the early stages, researchers paid great attention to the regulation of RTP performance in crystalline states. However, due to the complex preparation and poor processability of crystals, amorphous materials with RTP features have become a new research topic recently. This perspective aims to summarize the recent advances of RTP materials from crystalline to amorphous states, and analyze their molecular design strategies and luminescence mechanisms in detail. Finally, we prospect the future research directions of amorphous RTP materials. This perspective will provide a guideline for the future study of advanced RTP materials.

This paper presents a study on the degradation of Poly (lactic acid) (PLA), Poly (butylene abdicate—terephthalate) (PBAT) and their blends with different proportions in the environment of digested sludge. The degradation rates of PLA and PBAT were obtained through anaerobic reaction device. The samples obtained at regular intervals were measured and analyzed by differential scanning calorimeter (DSC), infrared spectrometer (FTIR) and scanning electron microscope (SEM) respectively. The results showed that the degradation rate of PLA was higher than that of PBAT under the same degradation environment and degradation time. DSC results showed that the degradation rate of PLA in the amorphous phase was slowed by the influence of PBAT. The characteristic peaks of the materials on the infrared spectrum shifted after degradation which implicit the degradation occurs. At the microscopic level, numerous protruding ribs in the material can be seen in the electron micrograph. Obviously, the samples can be degraded under the environment of digested sludge.

A wide variety of experimental results and theoretical investigations in recent years have convincingly demonstrated that several transition metal oxides and other materials have dominant states that are not spatially homogeneous. This occurs in cases in which several physical interactions--spin, charge, lattice, and/or orbital--are simultaneously active. This phenomenon causes interesting effects, such as colossal magnetoresistance, and it also appears crucial to understand the high-temperature superconductors. The spontaneous emergence of electronic nanometer-scale structures in transition metal oxides, and the existence of many competing states, are properties often associated with complex matter where nonlinearities dominate, such as soft materials and biological systems. This electronic complexity could have potential consequences for applications of correlated electronic materials, because not only charge (semiconducting electronic), or charge and spin (spintronics) are of relevance, but in addition the lattice and orbital degrees of freedom are active, leading to giant responses to small perturbations. Moreover, several metallic and insulating phases compete, increasing the potential for novel behavior.

Background/Objectives: Selective laser sintering (SLS) is one of the most promising 3D printing techniques for pharmaceutical applications as it offers numerous advantages, such as suitability to work with already approved pharmaceutical excipients, the elimination of solvents, and the ability to produce fast-dissolving, porous dosage forms with high drug loading. When the powder mixture is exposed to elevated temperatures during SLS printing, the active ingredients can be converted from the crystalline to the amorphous state, which can be used as a strategy to improve the dissolution rate and bioavailability of poorly soluble drugs. This study investigates the potential application of SLS 3D printing for the fabrication of tablets containing the poorly soluble drug carvedilol with the aim of improving the dissolution rate of the drug by forming an amorphous form through the printing process. Methods: Using SLS 3D printing, eight tablet formulations were produced using two different powder mixtures and four combinations of experimental conditions, followed by physicochemical characterization and dissolution testing. Results: Physicochemical characterization revealed that at least partial amorphization of carvedilol occurred during the printing process. Although variations in process parameters were minimal, higher temperatures in combination with lower laser speeds appeared to facilitate a greater degree of amorphization. Ultimately, the partial conversion to the amorphous form significantly improved the dissolution of carvedilol compared to its pure crystalline form. Conclusions: Obtained results suggest that the SLS 3D printing technique can be effectively used to convert poorly water-soluble drugs to their amorphous state, thereby improving solubility and bioavailability.

Plastic waste from fossil‐derived polymers remains a major environmental challenge, driving interest in biopolymers and enzyme‐enabled end‐of‐life strategies. This review synthesizes current understanding of how polymer structure and thermal state govern enzymatic degradability, with emphasis on semicrystalline architectures and state‐dependent accessibility. Within the Keller–Flory two‐phase framework, crystalline lamellae embedded in an amorphous matrix dictate water/enzyme diffusion, chain mobility, and hydrolysis kinetics. Enzymatic attack preferentially initiates in amorphous regions, producing characteristic biphasic behavior as amorphous domains erode faster than crystalline regions, leading to crystallinity enrichment and subsequent slowing of degradation. Thermal transitions further modulate this balance: near or above Tg, segmental mobility and free volume rise, accelerating hydrolysis if enzymes remain stable; above Tm, chain mobility is maximal, but enzyme stability typically limits feasibility. Processing and architecture also strongly influence outcomes: annealing increases crystallinity and slows mass loss, quenching suppresses crystallization and hastens degradation, random copolymerization disrupts packing and lowers Tm, while block copolymers often degrade selectively by domain. Recent advances expand the operational window toward rubbery or near‐molten states for low‐melting aliphatic polyesters (e.g., PCL, PLGA, PEG‐b‐PLA), leveraging thermophilic/engineered hydrolases (cutinases, PETases, lipases, carboxylesterases) with demonstrated stability at 60–90 °C. Emerging strategies—including enzyme thermostabilization, AI‐guided design, disulfide grafting, smart encapsulation, and in‐situ enzyme embedding—enable self‐degradation of materials and accelerate inside‐out depolymerization under mild triggers. Integrating thermal analysis with polymer morphology and enzyme engineering offers a path to programmable, circular end‐of‐life for biopolymers, translating fundamental structure–property–reactivity relationships into practical enzymatic recycling and reduced environmental impact. This review explains how polymer morphology and thermal state shape enzymatic degradation pathways, comparing amorphous and molten biopolymer structures. By integrating structure–reactivity principles with insights from thermodynamics and enzyme engineering, it highlights mechanisms that enable efficient polymer breakdown. These concepts support the development of recyclable bioplastics and advance progress toward sustainable, circular polymer economies.

To investigate the impact of the surface functionalization of mesoporous silica nanoparticle (MSN) carriers in the physical state, molecular mobility and the release of Fenofibrate (FNB) MSNs with ordered cylindrical pores were prepared. The surface of the MSNs was modified with either (3-aminopropyl) triethoxysilane (APTES) or trimethoxy(phenyl)silane (TMPS), and the density of the grafted functional groups was quantified via 1H-NMR. The incorporation in the ~3 nm pores of the MSNs promoted FNB amorphization, as evidenced via FTIR, DSC and dielectric analysis, showing no tendency to undergo recrystallization in opposition to the neat drug. Moreover, the onset of the glass transition was slightly shifted to lower temperatures when the drug was loaded in unmodified MSNs, and MSNs modified with APTES composite, while it increased in the case of TMPS-modified MSNs. Dielectric studies have confirmed these changes and allowed researchers to disclose the broad glass transition in multiple relaxations associated with different FNB populations. Moreover, DRS showed relaxation processes in dehydrated composites associated with surface-anchored FNB molecules whose mobility showed a correlation with the observed drug release profiles.

The solubilization of poorly water-soluble drugs remains a critical challenge in pharmaceutical research. The formulation of solid dispersions employing mesoporous silica nanoparticles (MSN) constitutes a key strategy for enhancing the hydrophilicity and oral bioavailability of Biopharmaceutics Classification System (BCS) Class II drugs. Although several commercial mesoporous silica excipients have been approved for pharmaceutical use, there remains room for improvement regarding drug loading capacity, stability, and controllability of drug release. Methods: for this purpose, dendritic mesoporous silica nanoparticles (DMSN) with a radial dendritic structure and pH-responsive degradation properties were designed and synthesized using celecoxib (CEL) as the model drug, featuring a pore size of 21.51 nm. CEL was loaded onto DMSN and seven commercial solid dispersion excipients using the solvent evaporation method. Results: owing to its high surface area, pore volume, and radial structure, DMSN achieved 39.72% drug loading in an amorphous state, markedly improving wettability, dissolution, and physical stability. Accelerated stability tests showed that DMSN inhibited recrystallization, outperforming traditional solid dispersions. Pharmacokinetic studies in rats demonstrated that the oral bioavailability of CEL-DMSN was 1.29-fold higher than that of commercial celecoxib capsules. Conclusions: in conclusion, these results confirmed the potential of DMSN in enhancing the stability, promoting oral absorption, and reducing gastrointestinal irritation of poorly soluble drugs.

Thermophysical parameters of Finemet-type initially amorphous alloy produced using rapid quenching technique were determined. The temperature intervals of phase and structure changes have been obtained using calorimetry and non-ambient X-ray diffraction methods. The electric resistance data were recalculated to alloy electrical conductivity which it was recalculated to heat conductivity using the Wiedemann–Franz law. Resulting parameters were used for heat processes simulation that occurs in amorphous material of built-up transformer core during annealing in nanocrystallization temperature interval. Heat treatment of different sizes twisted magnetic cores was optimized.

Objective: The aim of this work is to improve the understanding of the mechanisms underlying the polymorphic transformations of pharmaceutical materials during milling. Elucidating these mechanisms is essential for controlling the polymorphism of active pharmaceutical ingredients and thereby improving their performance. Method: The structural evolution of various pharmaceutical compounds (sulfamerazine, glycine, mannitol, and famotidine) upon milling was followed using ex situ laboratory X-ray diffraction and in situ synchrotron measurements, complemented by DSC analyses. Results: For each compound, the kinetics of the polymorphic transformation was found to be sigmoidal and the presence of an intermediate amorphous phase during the transition from the initial to the final polymorphic form was also identified. Conclusions: The kinetic data obtained for sulfamerazine and glycine, together with the detection of an amorphous intermediate during the transformations of mannitol and famotidine, support the conclusion that milling-induced polymorphic transformations in pharmaceutical materials generally proceed via an amorphization–recrystallization mechanism.

This study aimed to investigate the role of micellization of sodium lauryl sulfate (SLS) in poloxamer 407 (POX)-based solid dispersions (POX-based SDs) using the anti-solvent method in enhancing the dissolution rate of practically water-insoluble cilostazol (CLT). Herein, SLS was incorporated into CLT-loaded SDs, at a weight ratio of 50:50:10 of CLT, POX, and SLS by three different methods: anti-solvent, fusion (60 °C), and solvent (ethanol) evaporation. The SDs containing micellar SLS in the anti-solvent method were superior in the transformation of the crystalline form of the drug into a partial amorphous state. It was notable that there was an existence of a hydrophobic interaction between the surfactant and the hydrophobic regions of polymer chain via non-covalent bonding and the adsorption of micellar SLS to the POX-based SDs matrix. Moreover, SLS micellization via the anti-solvent method was effectively interleaved in SDs and adhered by the dissolved CLT, which precluded drug particles from aggregation and recrystallization, resulting in improved SD wettability (lower contact angle) and reduced particle size and dissolution rate. In contrast, SDs without micellar SLS prepared by the solvent method exerted drug recrystallization and an increase of particle size, resulting in decreased dissolution. Incorporation of surfactant below or above critical micellar concentration (CMC) in SDs using the anti-solvent method should be considered in advance. Dissolution results showed that the pre-added incorporation of micellar SLS into POX-based SDs using the anti-solvent method could provide a way of a solubilization mechanism to enhance the dissolution rate of poorly water-soluble drugs.